Gold Nanoclusters as an Antibacterial Alternative Against Clostridium difficile

Antimicrobial Gold Nanoclusters: Recent Developments and Future Perspectives

(2019) Sibidou Yougbare et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Kaempferol conjugated gold nanoclusters enabled efficient for anticancer therapeutics to A549 lung cancer cells

(2019) Saravanan Govindaraju et al.   International Journal of Nanomedicine

Multifunctional Albumin-Stabilized Gold Nanoclusters for the Reduction of Cancer Stem Cells

(2019) Latorre et al.   Cancers

Dual Drug Backboned Shattering Polymeric Theranostic Nanomedicine for Synergistic Eradication of Patient-Derived Lung Cancer

(2018) Yuwei Cong et al.   ADVANCED MATERIALS

Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy

(2018) Guan-Jun Yang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Surface Ligand Chemistry of Gold Nanoclusters Determines Their Antimicrobial Ability

(2018) Kaiyuan Zheng et al.   CHEMISTRY OF MATERIALS

Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer

(2018) Wenli Qiu et al.   International Journal of Nanomedicine

Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China

(2017) Chunhui Li et al.   INFECTION

Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection

(2017) Vanessa W. Stevens et al.   JAMA Internal Medicine

Hospital-acquired Clostridium difficile infection in Mainland China: A seven-year (2009–2016) retrospective study in a large university hospital

(2017) Qiaomai Xu et al.   Scientific Reports

Clostridium difficile infection: epidemiology, diagnosis and understanding transmission

(2016) Jessica S. H. Martin et al.   Nature Reviews Gastroenterology & Hepatology

Breakthroughs in the treatment and prevention of Clostridium difficile infection

(2016) Larry K. Kociolek et al.   Nature Reviews Gastroenterology & Hepatology

Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects

(2016) Stefano Di Bella et al.   Toxins

Systematic Review: Adverse Events of Fecal Microbiota Transplantation

(2016) Sinan Wang et al.   PLoS One

Functional Gold Nanoparticles as Potent Antimicrobial Agents against Multi-Drug-Resistant Bacteria

(2014) Xiaoning Li et al.   ACS Nano

Balancing the Rate of Cluster Growth and Etching for Gram-Scale Synthesis of Thiolate-Protected Au25Nanoclusters with Atomic Precision

(2014) Xun Yuan et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection

(2014) D. Nathwani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular Epidemiology of Clostridium difficile Infection in a Major Chinese Hospital: an Underrecognized Problem in Asia?

(2013) P. M. Hawkey et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli

(2011) Yan Cui et al.   BIOMATERIALS

Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection

(2011) Ethan Gough et al.   CLINICAL INFECTIOUS DISEASES

Cytotoxicity of Nanoparticles

(2007) Nastassja Lewinski et al.   Small